
Monday, January 29, 2018 6:14:12 PM
the original S-1 came out back in October, the fact that a pricing has not been mentioned yet says that they are not ready to execute yet. Amending the S-1 only gives them rights to keep in on the table should they need to execute expeditiously. Just like a vote for future possible share increases....they are "Possible". Meaning could happen if/when the company decides it is necessary. My guess: If DCTH receives a lucrative offer from another company, (ATNX or not), they will consider the offer. If they don't like the offer, the S-1A will come into effect. For all we/you know, the company could be under a NDA at this time...maybe cleaning up the balance sheets and freeing up the patents was part of the plan to make an offer binding...again, SPECULATION!
Where do you get the idea that they are...
dilute by more than a quadruple
you are free to do as you see fit, but you can't judge those who are speculating a buyout, a partnership, or a acquisition. Do you have the inside information?
We go with the facts...ATNX is moving...DCTH is moving...does two plus two equal four? No one really knows...that is why we speculate on a message board instead of count our millions with Warren Buffet.
Best of Luck Buddy!
IMHO
In My Own Personal Opinion Of Course!

Liked By
Spread the love. Be the first to like this post!
Recent DCTH News
- Delcath Systems to Participate at the BTIG MedTech, Digital Health, Life Sciences & Diagnostic Tools Conference on February 14 to 16 • PR Newswire (US) • 01/30/2023 01:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/23/2023 12:01:47 PM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 01/23/2023 11:04:04 AM
- Delcath Systems Announces Updated Results from CHOPIN Phase 1b Trial Published in Cardiovascular and Interventional Radiology • PR Newswire (US) • 01/17/2023 01:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 01/10/2023 09:13:57 PM
- Securities Registration Statement (simplified Form) (s-3) • Edgar (US Regulatory) • 01/10/2023 09:08:24 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 12/29/2022 10:28:09 PM
- Tender Offer Statement by Issuer (sc To-i) • Edgar (US Regulatory) • 12/21/2022 05:18:41 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 12/16/2022 10:07:45 PM
- Delcath Systems Announces Inducement of Grant Under NASDAQ Listing Rule 5635(C)(4) • PR Newswire (US) • 12/16/2022 09:15:00 PM
- Small Company Offering and Sale of Securities Without Registration (d) • Edgar (US Regulatory) • 12/16/2022 08:04:28 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/16/2022 02:32:48 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/14/2022 09:55:08 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/14/2022 09:43:16 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 12/14/2022 08:35:42 PM
- Delcath Systems Closes Private Placement of $6.2 Million • PR Newswire (US) • 12/13/2022 01:30:00 PM
- Delcath Systems Announces Private Placement of $6.2 Million • PR Newswire (US) • 12/08/2022 01:30:00 PM
- Results of a Single Center Study on Delcath's CHEMOSAT® Hepatic Delivery System In the Treatment of Cholangiocarcinoma Published in the Journal Clinical & Experimental Metastasis • PR Newswire (US) • 12/05/2022 02:00:00 PM
- Delcath Systems (DCTH) Receives a Buy from H.C. Wainwright • TipRanks • 11/10/2022 11:35:43 AM
- Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH), Curis (CRIS) and AquaBounty Technologies (AQB) • TipRanks • 11/10/2022 11:21:12 AM
- Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 11/09/2022 09:15:00 PM
- Delcath Systems Reports Third Quarter 2022 Results and Provides Business Update • PR Newswire (US) • 11/08/2022 01:00:00 PM
- Delcath Systems to Host Third Quarter 2022 Results • PR Newswire (US) • 10/24/2022 08:05:00 PM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 09/16/2022 10:02:39 AM
- Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) • Edgar (US Regulatory) • 09/15/2022 09:13:03 PM
TNRG Files A Reg A Offering, To Raise $75 million • TNRG • Feb 1, 2023 10:07 AM
IQST - iQSTEL Announces Board Election and CPA Ratification Following Annual Shareholder Meeting • IQST • Feb 1, 2023 10:04 AM
1606 Corp. (OTC | CBDW) to Produce a New Inventory of CBD Smokables to Supply an Additional 2500 Retail Outlets, Engages Direct Marketing Expert to Head Efforts • CBDW • Feb 1, 2023 8:30 AM
ITRONICS RECEIVES VALUATION REPORT FOR ITS INTELLECTUAL PROPERTY TO OBTAIN NON-DILUTIVE FINANCING • ITRO • Feb 1, 2023 6:30 AM
Kona Gold Beverage, Inc Announces Distribution Agreement with Norman Distribution in Illinois • KGKG • Jan 31, 2023 9:00 AM
PSYC Provides Shareholders with Key Corporate Updates and Highlights Objectives for 2023 • PSYC • Jan 31, 2023 8:30 AM